Skip to main content
. Author manuscript; available in PMC: 2015 Aug 26.
Published in final edited form as: Nature. 2014 Dec 8;518(7540):552–555. doi: 10.1038/nature13968

Extended Data Table 3. Prior banked tissue samples in patients with t-AML/t-MDS with clonal TP53 mutations.

All patients had one or more clonal TP53 mutation in their diagnostic t-AML/t-MDS samples (530447 had biallelic mutations). Cases in which the prior banked sample had detectable TP53 mutated cells are highlighted in red. See Suppl. Table 1 for the clinical and molecular features of these cases. BM FFPE: formalin-fixed parafin-embedded sample; BM flow: snap frozen bone marrow leukocyte pellet.

Patient TP53 mutation in t-AML/t-MDS
Prior banked tissue sample
Position (Chr 17) Mutation Coding change Year of Banking Year of Diagnosis Prior Banked Tissue
236041 7,518,261 T to A R249W 2007 2011 BM FFPE
341666 7,518,988 G to A R196* 2002 2005 Pharesis
530447 7,519,238 C to G K139N 2001 2007 Pharesis
530447 7,518,263 C to T R248Q 2001 2007 Pharesis
648904 7,514,759 C to T Exon 9 splice site 2001 2004 Pharesis
756582 7,519,015 C to T Exon 6 splice site 1999 2007 Pharesis
895681 7,519,119 T to A H179L 2000 2006 BM FFPE
967645 7,518,915 T to C Y220C 2005 2010 BM Flow